Shilpa Medicare Limited has announced the successful closure of inspection, with the receipt of Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at API manufacturing site located at Raichur, Karnataka, India for the inspection conducted during the period 22nd July, 2019 to 26th July, 2019.
Shares of SHILPA MEDICARE LTD. was last trading in BSE at Rs.290 as compared to the previous close of Rs. 295.2. The total number of shares traded during the day was 133 in over 28 trades.
The stock hit an intraday high of Rs. 293.2 and intraday low of 290. The net turnover during the day was Rs. 38716.